CDKN2B and prostate carcinoma: While the INK4b/ARF/INK4a locus is shown to undergo deletion in GBM [26], epigenetic transcriptional repression of the locus by a repressive complex containing ANRIL and CBX7 has also been shown in prostate cancer [27].